Vascular Disease In Women

Take advantage of new insights into prevention, diagnosis and treatment of coronary heart disease in women -- to the benefit of your patients. Designed to optimize your daily practice, this book gives lucid, up-to-date answers to numerous questions: What are the risks and benefits of hormone replacement therapy? What are the major risk factors for coronary heart disease in women? What are the most appropriate diagnostic tests in women? Which is the better treatment option for the woman with myocardial infarction -- lysis or primary angioplasty?

Vascular Disease in Women highlights the epidemiology, natural history and treatment of vascular disease, specifically as it pertains to women. The book provides a thorough overview of what is known and waht is now known about vascular disease in women and highlights opportunities for further education and research on this topic. The book will serve as an essential reference for both clinicians and researchers, discussing the disease prevalence, treatment options, and treatment outcomes for vascular disease in women and explores the need for future research in vascular disease specifically as it pertains to women. Provides a comprehensive overview of vascular disease as it affects women Includes contributions from world-renowned vascular surgeons of both genders, who have a vested interest in women’s vascular health Covers what is known and not known about vascular disease in women, prompting further research in the area for what is still unknown

Despite being one of the world's biggest killers of women, heart disease is under-diagnosed, under-treated, and under-managed. Why? What is going wrong? Important and ground-breaking, Women and Heart Disease brings our attention to the inadequacies in both the diagnosis and treatment of heart disease in women. Key features: * written by Nanette Wenger and Peter Collins, two of the worlds leading cardiologists * contributions from leaders in women‘s cardiac health * covers all aspects of cardiovascular disease, not just coronary artery disease * fully updated. Building on the success of the best-selling first edition, this is essential reading for all physicians with a particular interest in women and heart disease.

Cardiovascular disease is the leading cause of death in women in the US, with more women dying from heart disease than men. Women may have different presentation from men and often need a different approach to diagnosis and treatment. There are also unique topics of management of heart disease in women, including issues during pregnancy, lactation, and menopause. Many different health care providers, as well as cardiologists are involved in treating these patients. A manual reviewing diagnosis and treatment of cardiac disease in women would help providers without specific cardiology training to deliver care with greater efficiency. A practical and comprehensive guide geared towards these providers would be a highly practical and valuable resource that would be utilized in everyday practice in offices that include urban clinics, general medicine offices, obstetrics and gynecology offices, as well as in the surgical subspecialties. This book will be a highly practical resource that can be directly applied to the issues that arise in everyday practice. There is no available book on the market that focuses on a broader approach to cardiac disease in women or focuses on non-cardiology providers (and their trainees) who have the need to know more about treatment of cardiovascular disease in women.​

Heart disease remains the leading cause of morbidity and mortality in the industrialized countries and can occur in men and women of any age. The contributors to this special issue, all of them leading authors in the field, focus on cardiovascular disease in women. As a result, this publication gives an up-to-date overview of the latest developments in this particular field, with information ranging from basic concepts to the treatment of women patients and including social aspects. The articles discuss topics such as coronary artery disease and its prevention, myocardial infarction and its treatment, congestive heart failure, stroke, peripheral vascular disease, estrogen replacement as well as on-going clinical trials. 'Cardiovascular Disease in Women' takes a further step towards the solving of an international health care problem and will be of interest to practising physicians, nurses, students of medicine and clinical researchers all over the world.

This is a groundbreaking book which explains the important clinical and surgical aspects of the diagnosis and treatment of heart disease in women, and seeks to improve the understanding of the difference gender makes to both the presentation of heart disease and the disease itself.

This practical resource takes a close look at an emerging issue in woman's health*the gender difference in cardiovascular disease. Health care providers involved in the care of female patients can rely on this extraordinary reference for the latest coverage of cardiovascular health and disease. The new 2nd Edition features an expanded scope that offers more information on patient care approaches, risk factors, hormones and CAD, and more. New chapters cover hot topics such as estrogen, diet and nutrition, first- and second-degree prevention strategies, managing CAD, and acute coronary syndromes. A much broader scope presents more information on patient care, risk factors, hormones and CAD, and clinical manifestations of CAD. New authors bring an up-to-date perspective to material that focuses on their areas of expertise. New chapters provide the latest information on hot topics, including: Nutrition, Antioxidants and Inflammation, Primary Prevention in Women, Lessons from Human Trials, Management of Chronic Stable Angina, Acute Coronary Syndromes, Angiography and Angioplasty, Coronary Artery Surgery, Implementation Strategies for Secondary Prevention, Syndrome X and Coronary Vascular Resistance, and Normal Cardiovascular Physiology Updates and new information have been incorporated throughout, and substantial revisions have been made to chapters on: Diabetes Mellitus and Obesity, Smoking, Clotting and Thrombosis, Physical Activity, Lessons from Animal Models, Prescribing HRT, Diagnostic Testing Valvular Heart Disease, CHF and Myocardial Dysfunction, Stroke and PVD, Preexisting Heart Disease, and Diagnostic and Therapeutic Strategies Expanded discussions of estrogen address both the underlying science and clinical applications for practice Strategies for first- and second-degree prevention of disease offer a proactive approach to treatment and patient care

Cardiovascular disease is a leading cause of illness and death. With increasing recognition that aspects of its prevention, treatment and management are unique to women, this report focuses on the impact of cardiovascular disease on the health of Australian women. Over half a million Australian women had 1 or more heart, stroke and vascular diseases in 2017-18, and more than 22,200 died from cardiovascular disease in 2016.

With the numerous advances that have been made in treatment of heart disease over the past 20 years, physicians are now emphasizing more than ever the prevention of heart disease. This issue provides cardiologists with practical state-of-the-art information on prevention that can be be easily applied to their patients. Topics covered include diabetes, lipid-lowering therapy, RAAS blockade, emerging therapies for atherosclerosis prevention, and heart disease in women.

This book reviews all aspects of the diagnosis and management of heart disease in women, covering areas such as gender differences in metabolic syndrome, hypertension and atherogenesis. Gender differences in cardiovascular diseases are widespread, but while gender medicine takes into account the effects of sex and gender on the health of women and men, traditionally, women have been underrepresented in cardiovascular clinical trials, in management of different cardiac diseases and drug use. Gender Differences in the Pathogenesis and Management of Heart Disease deals with the gender-specific differences in cardiac physiology and diseases and brings into perspective the critical significance of gender in management of cardiovascular disease presentations and management. As such it is of enormous use to all clinical staff who manage women with cardiovascular disease.

A comprehensive review the state-of-the-art in atherosclerosis of the arteries of the legs and feet. The authors discuss in detail the primary symptom-claudication-an intermittent pain in the leg or foot while walking, its predisposing factors, the current diagnostic methodologies, the impressive advances in the therapeutic armamentarium, and the need to screen for co-existing coronary artery disease. Additional chapters describe cutting-edge noninvasive angiography and vascular flow studies, specific drug therapy for claudication, regression of atherosclerosis therapy, gene therapy, and drug eluting stents for peripheral arterial disease. The authors also examine the epidemiology of LEAD, the effects of smoking and effective smoking cessation programs, its pathogenesis and its association with lipid abnormalities and hypertension, aggressive risk factor modification, and the need to measure the ankle brachial index of every patient over 45.

This book brings together specialist authors from a variety of medical disciplines to give comprehensive coverage of the whole spectrum of women's vascular health. Covering coronary artery disease and its precursors, venous disease, thrombophilic defects, hormonal therapy and haemorrhagic problems, the content is divided into three sections. Section one reviews generic issues including the pathophysiology of arteriosclerosis, metabolic factors in vascular disease, the epidemiology and management of CHD in women. The management of cardiac syndrome X and the problem of diabetes are also discussed here. The second section looks at women's vascular health as it applies to fertility issues and during pregnancy such as polycystic ovarian disease, menstrual dysfunction, the menopause, venous thromboembolism and haemorrhagic problems. In the concluding third section, hormonal therapy in women and in particular the oral contraceptive pill and hormone replacement therapies are covered. The reader will be given a clear overview of the potential mechanisms whereby such therapy can act as a risk factor for arterial and venous disease, and will receive clear guidance regarding prescribing.

Cardiovascular disease is the leading cause of death and disability in the world. It is largely preventable, and can certainly be delayed by attention to established risk factors. Primary care is the natural and most appropriate location for cardiovascular prevention. This accessible and practical reference and everyday manual covers the organisation of prevention services, estimating risk and using guidelines, and examines each key area with extensive use of clinical case studies. It provides the information necessary to answer the concerns of patients on areas such as cholesterol, diet, exercise, alcohol, smoking and medication. General practitioners, practice nurses, physiotherapists, dieticians and pharmacists will find this book to be an essential aid to their daily work.

Despite media attention and public awareness, recent advances in pharmaceutical and medical developments, heart disease in women is under-diagnosed, under-treated, and under-managed. Many women fail to present in the clinic when symptomatic, because of responsibilities at home or at work. Often the first presentation follows a cardiac event. Women are excluded from many clinical trials regardless of age or cardiac history, simply because most trials are aimed at male patients. This best-selling, updated title, aimed at changing this treatment of women's cardiac issues, covers all aspects of female cardiovascular disease. It is required reading for all practitioners who assess female patients.

This issue of Primary Care: Clinics in Office Practice, Guest Edited by Dr. Mark B. Stephens, is devoted to Cardiovascular Disease. Articles in this issue include: State of the Heart: Overview of disease burden of cardiovascular disease from an epidemiologic perspective; Heavy Heart: Economic burden of heart disease with projections/implications for impact on the health care system; Prevention of Heart Disease; Coronary Artery Disease; Congestive Heart Failure; Valvular Heart Disease; Peripheral Vascular Disease; The Athlete’s Heart and Sudden Death; Metabolic Syndrome: systems thinking in heart disease; Women and Heart Disease; Heart Disease in Children; and Cardiac Imaging.

Cardiovascular Diseases—Advances in Research and Treatment: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Vascular Diseases. The editors have built Cardiovascular Diseases—Advances in Research and Treatment: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Vascular Diseases in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Cardiovascular Diseases—Advances in Research and Treatment: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

This book brings together specialist authors from a variety of medical disciplines to give comprehensive coverage of the whole spectrum of women's vascular health. Covering coronary artery disease and its precursors, venous disease, thrombophilic defects, hormonal therapy and haemorrhagic problems, the content is divided into three sections. Sectio

Cardiovascular disease is the number one killer of both men and women in the US and Europe today. Over the last 20 years, many innovations in technology have allowed for improved therapies for heart attack and stroke and overall outcomes have significantly improved. Death rates from cardiovascular disease in men are declining.However, even with these improvements in care, death rates for women remain unchanged. This book will explore these gender disparities in care in depth — specific sections will be devoted to answering the questions of why they are occurring and what healthcare providers and women can do to effect change and narrow the gender gap in cardiovascular care.Ultimately, this book is designed to open the eyes of healthcare providers, medical professionals and policy makers — as well as potential female patients — and should serve as a “call to action” to promote better cardiovascular care for women. Through education, awareness and advocacy women worldwide will benefit, the gap will begin to close and better cardiovascular care can be provided for all.